- Preamble [SYSTEM]
- Fund & Investor Interest
- Street Moves
- Solebury Trout Updates
- Market Commentary
- IPO News
- Expert Interactions
- Banker Comments & Notes
- Conference Snippet
- Industry Snippets
- Social Media
- Solebury Trout Talks

IPO News: Filed S-1/A: Inari Medical Launches 7.3mm Share IPO with $14-$16 Marketing Range
Inari Medical
Nasdaq: NARI
Filing Date: 02/21/20
Launch Date: 05/18/20
Price Range: $14.00 - $16.00
Shares Offered (Pre-Shoe, mm): 7.3
Primary Shares (mm): 7.3
Secondary Shares (mm): 0.0
Amount Offered (@ Midpoint)(mm): $110.0
% Secondary: 0.0%
Shares Outstanding (mm): 46.1
Market Value at IPO Midpoint (mm): $691.2
Offering as % of Market Value: 15.9%
Active Bookrunners: Bank of America | Morgan Stanley
Passive Bookrunner: Wells Fargo
Co-Manager: Canaccord Genuity
Major Holders: US Venture Partners | Gilde Healthcare Partners | Versant Venture Partners | Milder Community Property Trust | CVF
Description: Inari is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Their initial product offering consists of two minimally-invasive, novel catheter-based mechanical thrombectomy devices.
Note: Emerging Growth Company